Zelio E-Mobility Approved by BSE for Rs. 16.5 Crore Preferential Equity and Convertible Warrant Issue
9,73,000 equity shares for non-promoters and 9,96,000 warrants for promoters priced at Rs. 853 each approved by BSE
Zelio E-Mobility Limited has received in-principle approval from BSE for issuing 9,73,000 equity shares and 9,96,000 convertible warrants at a price not less than Rs. 853 each, raising over Rs. 16.5 crore through a preferential allotment to promoters and non-promoters.
Zelio E-Mobility Limited
Preferential Issue
Zelio E-Mobility Limited has obtained in-principle approval from BSE to issue 9,73,000 equity shares and 9,96,000 convertible warrants in a preferential allotment at a price of Rs. 853 per share or warrant, targeting both non-promoter and promoter investors.
The approval covers the issuance of 9,73,000 equity shares with a face value of Rs. 10 each at a price not lower than Rs. 853 per share, allocated to non-promoter investors on a preferential basis.
In addition, the company will issue 9,96,000 convertible warrants, each convertible into one equity share of Rs. 10 face value, to promoters at the same price of Rs. 853 per warrant.
This preferential issue will help Zelio E-Mobility raise significant capital by targeting distinct investor categories, contributing to their financial strategy as approved by the stock exchange.
The company shared the in-principle approval via a letter dated November 19, 2026, complying with SEBI regulations governing preferential allotments.
Highlights
- BSE granted in-principle approval on November 19, 2026, under SEBI Listing Regulations.
- Issuance of 9,73,000 equity shares to non-promoter investors at Rs. 853 per share.
- Issuance of 9,96,000 convertible warrants to promoters at Rs. 853 per warrant, convertible into equity shares.
- Face value of each share or warrant is Rs. 10.
- Total capital raise exceeds Rs. 16.5 crore through preferential allotment.
Key Data Snapshot
What happened
- Zelio E-Mobility Limited received in-principle approval from BSE Limited on November 19, 2026.
- Approval pertains to preferential issue of equity shares and convertible warrants under SEBI Listing Regulations.
Key details
- 9,73,000 equity shares to be issued to non-promoter category investors at Rs. 853 per share.
- 9,96,000 convertible warrants to be issued to promoters at Rs. 853 per warrant, each convertible into one equity share.
- Face value of each equity share and warrant is Rs. 10.
Funding and capital details
- The issue will raise significant capital through preferential allotment.
- Shares and warrants are issued at a premium price of Rs. 853 per unit.
Regulatory and governance context
- The issuance follows Regulation 28(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- BSE granted approval for the preferential issue based on the company's application and relevant compliance.
Highlights
- BSE granted in-principle approval on November 19, 2026, under SEBI Listing Regulations.
- Issuance of 9,73,000 equity shares to non-promoter investors at Rs. 853 per share.
- Issuance of 9,96,000 convertible warrants to promoters at Rs. 853 per warrant, convertible into equity shares.
- Face value of each share or warrant is Rs. 10.
- Total capital raise exceeds Rs. 16.5 crore through preferential allotment.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 28(1)
Convertible warrants to be allotted to promoters on preferential basis.
More News on Preferential Issue
View allLatest corporate announcements and market updates in Preferential Issue.
Jubilant Pharmova Receives Shareholder Approval for Private Placement of Non-Convertible Debentures
Jubilant Pharmova Limited has obtained shareholder approval through a postal ballot conducted on November 20, 2026, for the issuance of Non-Convertible Debentures on a private placement basis, allowing the company to raise debt capital.
Read Full StoryIndian Bank Approves Rs. 3000 Crore Additional Capital Raise via Basel III AT1/Tier 2 Bonds for FY 2026-27
Indian Bank's Board of Directors approved raising an additional Rs. 3000 crore through Basel III compliant Additional Tier 1 (AT1) or Tier 2 Bonds, increasing its total capital raising approval to Rs. 5000 crore for the financial year 2026-27.
Read Full StoryDEE Development Engineers Corrects ESOP Share Allotment, Issues 1,20,784 Equity Shares Raising Paid-up Capital
DEE Development Engineers Limited issued 1,20,784 equity shares under its Employee Stock Option Scheme on 6 November 2026, correcting a previously disclosed lower figure. This allotment raised the company's paid-up capital to Rs. 75,36,02,220, with the shares carrying a face value of Rs. 10 each.
Read Full Story